Motus GI Holdings – Consensus Indicates Potential 157.7% Upside

Broker Ratings

Motus GI Holdings with ticker code (MOTS) now have 6 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 3 and 2 and has a mean target at 2.5. Now with the previous closing price of 0.97 this indicates there is a potential upside of 157.7%. The 50 day moving average now sits at 0.9 while the 200 day moving average is 1.05. The market capitalisation for the company is $32m. You can visit the company’s website by visiting: http://www.motusgi.com

Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index